Moderate-to-vigorous physical activity guideline adherence was associated with a 22% and 17% lower CHD risk in women and men, respectively.

There was a significant association between early age of natural menopause vs late age and metabolic syndrome.

Type 2 diabetes prevalence among children aged 5 years or less is associated with social and environmental factors.

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.

Ustekinumab and vedolizumab have comparable safety and efficacy in older and younger adults with IBD, indicating that age should not be a deterrent for treatment.

The presence of metabolic dysfunction-associated steatotic liver disease may be a predictor of disease trajectory in patients with MACE.